Antioxidants and Redox Signaling · 2012 · 155 citations · 30 references
The excess of ROS from NAD(P)H Oxidase and/or mitochondria and the increased vascular COX-2/TP receptor axis act in concert to induce vascular dysfunction and hypertension.
30
Therapeutic Targeting of Mitochondrial Superoxide in Hypertension
Anna Dikalova, Alfiya Bikineyeva, Klaudia Budzyn et al. · Circulation Research · 2010 · 719 citations · Full text
Ying Xia, Gabriela García, Daniel Hwang et al. · Journal of Clinical Investigation · 1995 · 485 citations · Full text
Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice
Agostino Virdis, Mário Fritsch Neves, Farhad Amiri et al. · Journal of Hypertension · 2004 · 243 citations
Davide Gianni, Nicolas Taulet, Hui Zhang et al. · ACS Chemical Biology · 2010 · 185 citations
Specific Nadph Oxidase-1, Nadph Oxidase, Small-molecule Inhibitor Blocks +18